The experimental intervention PEGASUSTreatment as usual
The experimental intervention PEGASUS: See arm description.
Treatment as usual: See arm description
Study summary
The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Participating Patients
Inclusion Criteria:
* Must be able to give an informed written consent.
* Must be newly accepted in the pre-planned BPD treatment packages.
* ≥18 years of age.
* Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives").
* Capable of reading and understanding Danish.
Exclusion Criteria:
* None\*
* Note that to get accepted into a treatment package for BPD, patients must not fulfill the criteria for a F20 diagnosis or the criteria for alcohol or substance abuse or harmful use.
Participating Relatives:
Inclusion Criteria:
* Must be able to give an informed written consent.
* ≥18 years of age.
* Capable of reading and understanding Danish.
Exclusion criteria: None
Primary outcome measure(s)
Level of functioning — Study inclusion and at 9 months at study completion WHODAS 2.0, 36-item interviewer-administered version (WHO's Disability Assessment Schedule). Measured in patients.
Trial sites (1)
Facility
City
Region
Status
Copenhagen Research Center for Mental Health - CORE
Copenhagen
Denmark
Recruiting
More University Hospital Bispebjerg and Frederiksberg trials in Denmark
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.